Ronald Gerardo Garcia, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vagus Nerve Stimulation | 9 | 2023 | 228 | 1.680 |
Why?
|
| Vagus Nerve | 6 | 2023 | 460 | 1.110 |
Why?
|
| Depressive Disorder, Major | 6 | 2021 | 4808 | 0.810 |
Why?
|
| Brain Stem | 5 | 2023 | 853 | 0.740 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 5 | 2023 | 170 | 0.670 |
Why?
|
| Autonomic Nervous System | 4 | 2015 | 706 | 0.620 |
Why?
|
| Vasodilation | 4 | 2011 | 970 | 0.530 |
Why?
|
| Phantom Limb | 1 | 2016 | 107 | 0.460 |
Why?
|
| Colombia | 13 | 2015 | 287 | 0.450 |
Why?
|
| Garlic | 1 | 2013 | 29 | 0.420 |
Why?
|
| Blood Vessels | 1 | 2019 | 1113 | 0.420 |
Why?
|
| Mercury Poisoning | 1 | 2012 | 32 | 0.400 |
Why?
|
| Pre-Eclampsia | 6 | 2012 | 1261 | 0.360 |
Why?
|
| Migraine Disorders | 3 | 2017 | 1732 | 0.340 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2019 | 1496 | 0.340 |
Why?
|
| Heart Rate | 8 | 2020 | 4204 | 0.330 |
Why?
|
| Nitrates | 1 | 2011 | 260 | 0.330 |
Why?
|
| Plant Extracts | 1 | 2013 | 496 | 0.320 |
Why?
|
| Endothelium, Vascular | 6 | 2019 | 4427 | 0.300 |
Why?
|
| Affect | 1 | 2015 | 1500 | 0.290 |
Why?
|
| Adiponectin | 1 | 2013 | 1119 | 0.270 |
Why?
|
| Hyperinsulinism | 1 | 2009 | 402 | 0.270 |
Why?
|
| Arginine | 2 | 2008 | 933 | 0.270 |
Why?
|
| Memory | 1 | 2015 | 2190 | 0.250 |
Why?
|
| Hydrocephalus | 1 | 2012 | 762 | 0.250 |
Why?
|
| Population | 1 | 2005 | 140 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2021 | 36532 | 0.230 |
Why?
|
| Exercise | 2 | 2019 | 5937 | 0.220 |
Why?
|
| Brachial Artery | 4 | 2011 | 375 | 0.210 |
Why?
|
| Diabetic Angiopathies | 1 | 2008 | 805 | 0.210 |
Why?
|
| Myocardial Infarction | 3 | 2015 | 11499 | 0.200 |
Why?
|
| Nausea | 2 | 2015 | 680 | 0.190 |
Why?
|
| Brain | 6 | 2021 | 27171 | 0.180 |
Why?
|
| Neural Pathways | 4 | 2016 | 3085 | 0.180 |
Why?
|
| C-Reactive Protein | 3 | 2008 | 3850 | 0.180 |
Why?
|
| Fibromyalgia | 2 | 2015 | 406 | 0.170 |
Why?
|
| Case-Control Studies | 12 | 2017 | 22223 | 0.160 |
Why?
|
| Meditation | 1 | 2022 | 256 | 0.160 |
Why?
|
| Heart | 1 | 2012 | 4414 | 0.160 |
Why?
|
| Patient Readmission | 1 | 2012 | 3286 | 0.150 |
Why?
|
| Depression | 3 | 2021 | 8237 | 0.150 |
Why?
|
| Adult | 30 | 2022 | 223044 | 0.150 |
Why?
|
| Female | 39 | 2021 | 396112 | 0.140 |
Why?
|
| Aphasia | 1 | 2019 | 191 | 0.140 |
Why?
|
| Male | 30 | 2020 | 363698 | 0.140 |
Why?
|
| Respiration | 2 | 2020 | 1653 | 0.130 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2007 | 532 | 0.130 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2016 | 143 | 0.130 |
Why?
|
| Cerebral Cortex | 3 | 2016 | 5767 | 0.130 |
Why?
|
| Humans | 49 | 2023 | 765968 | 0.120 |
Why?
|
| Double-Blind Method | 6 | 2019 | 12437 | 0.120 |
Why?
|
| Primary Dysautonomias | 1 | 2015 | 28 | 0.120 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 717 | 0.120 |
Why?
|
| Insulin Resistance | 4 | 2010 | 3985 | 0.120 |
Why?
|
| Cardiovascular Diseases | 5 | 2019 | 15652 | 0.110 |
Why?
|
| Low Back Pain | 1 | 2022 | 987 | 0.110 |
Why?
|
| Vomiting | 1 | 2016 | 647 | 0.110 |
Why?
|
| Young Adult | 10 | 2019 | 59889 | 0.100 |
Why?
|
| Middle Aged | 16 | 2019 | 223009 | 0.100 |
Why?
|
| Photic Stimulation | 2 | 2015 | 1993 | 0.100 |
Why?
|
| Nitric Oxide | 3 | 2010 | 2143 | 0.100 |
Why?
|
| Amygdala | 1 | 2020 | 1377 | 0.100 |
Why?
|
| Ecuador | 2 | 2015 | 62 | 0.100 |
Why?
|
| Mental Recall | 2 | 2015 | 1218 | 0.090 |
Why?
|
| Supine Position | 1 | 2012 | 209 | 0.090 |
Why?
|
| Linear Models | 2 | 2012 | 5876 | 0.090 |
Why?
|
| Delirium | 1 | 2023 | 1707 | 0.090 |
Why?
|
| Somatosensory Cortex | 1 | 2015 | 510 | 0.090 |
Why?
|
| Pain | 2 | 2017 | 5077 | 0.090 |
Why?
|
| Pregnancy Proteins | 1 | 2012 | 225 | 0.090 |
Why?
|
| Exercise Test | 1 | 2019 | 2180 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2015 | 1255 | 0.090 |
Why?
|
| Nitrites | 1 | 2011 | 156 | 0.090 |
Why?
|
| Colorimetry | 1 | 2011 | 148 | 0.090 |
Why?
|
| Diet Surveys | 2 | 2012 | 1159 | 0.090 |
Why?
|
| Electrocardiography | 5 | 2019 | 6404 | 0.090 |
Why?
|
| Meglumine | 1 | 2010 | 143 | 0.080 |
Why?
|
| Hyperemia | 1 | 2011 | 224 | 0.080 |
Why?
|
| Prediabetic State | 1 | 2015 | 548 | 0.080 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 1381 | 0.080 |
Why?
|
| Cardiovascular System | 1 | 2017 | 841 | 0.080 |
Why?
|
| Nutrition Assessment | 1 | 2012 | 738 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 12240 | 0.080 |
Why?
|
| Hypotension, Orthostatic | 1 | 2012 | 257 | 0.080 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 643 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 39193 | 0.080 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2010 | 137 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 561 | 0.080 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2012 | 395 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2015 | 1410 | 0.080 |
Why?
|
| Models, Theoretical | 2 | 2012 | 3564 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 1478 | 0.070 |
Why?
|
| Cerebellum | 1 | 2015 | 1518 | 0.070 |
Why?
|
| Hippocampus | 1 | 2020 | 3775 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6203 | 0.070 |
Why?
|
| Hypertension | 3 | 2020 | 8626 | 0.070 |
Why?
|
| Prospective Studies | 8 | 2019 | 54802 | 0.070 |
Why?
|
| Obesity | 2 | 2008 | 13076 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2015 | 1393 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 644 | 0.070 |
Why?
|
| Pregnancy | 11 | 2012 | 30260 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2108 | 0.070 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2006 | 13 | 0.070 |
Why?
|
| Adolescent | 9 | 2019 | 88835 | 0.070 |
Why?
|
| Blood Pressure | 4 | 2020 | 8532 | 0.070 |
Why?
|
| Nutritional Status | 2 | 2012 | 1620 | 0.060 |
Why?
|
| Physical Examination | 1 | 2012 | 1266 | 0.060 |
Why?
|
| Syncope, Vasovagal | 1 | 2006 | 38 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2012 | 937 | 0.060 |
Why?
|
| Brain Mapping | 3 | 2016 | 6601 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1989 | 0.060 |
Why?
|
| Body Mass Index | 5 | 2012 | 13039 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 1375 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2005 | 157 | 0.060 |
Why?
|
| Counseling | 1 | 2012 | 1551 | 0.060 |
Why?
|
| Brain Ischemia | 2 | 2019 | 3000 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2007 | 521 | 0.060 |
Why?
|
| Waist-Hip Ratio | 1 | 2005 | 520 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2012 | 2499 | 0.060 |
Why?
|
| Prolactin | 1 | 2006 | 625 | 0.050 |
Why?
|
| Diet | 2 | 2012 | 8086 | 0.050 |
Why?
|
| Solitary Nucleus | 1 | 2023 | 55 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2017 | 2895 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2817 | 0.050 |
Why?
|
| Calcium | 2 | 2006 | 5767 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2007 | 697 | 0.050 |
Why?
|
| Length of Stay | 2 | 2015 | 6485 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2334 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2015 | 41649 | 0.050 |
Why?
|
| Serotonin | 1 | 2007 | 1049 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12056 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 6014 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2012 | 2643 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2012 | 4025 | 0.050 |
Why?
|
| Anxiety | 1 | 2016 | 4671 | 0.050 |
Why?
|
| Comorbidity | 2 | 2012 | 10563 | 0.040 |
Why?
|
| Health Promotion | 1 | 2012 | 2208 | 0.040 |
Why?
|
| Health Services | 1 | 2005 | 756 | 0.040 |
Why?
|
| Recurrence | 1 | 2012 | 8501 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 40065 | 0.040 |
Why?
|
| Developing Countries | 1 | 2012 | 2911 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2007 | 1402 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2012 | 3461 | 0.040 |
Why?
|
| Employment | 1 | 2005 | 1106 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5343 | 0.040 |
Why?
|
| Respiratory Rate | 1 | 2020 | 179 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2017 | 4628 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2006 | 2599 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2012 | 5912 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2006 | 1827 | 0.040 |
Why?
|
| ROC Curve | 1 | 2005 | 3620 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2005 | 1160 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2012 | 4533 | 0.030 |
Why?
|
| Aged | 6 | 2023 | 171117 | 0.030 |
Why?
|
| Insulin | 2 | 2008 | 6599 | 0.030 |
Why?
|
| Homeostasis | 1 | 2007 | 3336 | 0.030 |
Why?
|
| Heart Failure | 2 | 2017 | 11840 | 0.030 |
Why?
|
| Stroke | 2 | 2019 | 9747 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 3110 | 0.030 |
Why?
|
| Risk Factors | 6 | 2015 | 74840 | 0.030 |
Why?
|
| Motion Sickness | 1 | 2015 | 33 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 240 | 0.030 |
Why?
|
| Trigeminal Nerve | 1 | 2016 | 253 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 2897 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2017 | 490 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2015 | 403 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 2015 | 193 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 26318 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15398 | 0.030 |
Why?
|
| Oxygen | 2 | 2015 | 4241 | 0.030 |
Why?
|
| Galvanic Skin Response | 1 | 2014 | 359 | 0.020 |
Why?
|
| Pressure | 1 | 2015 | 1168 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2017 | 978 | 0.020 |
Why?
|
| Blood Glucose | 3 | 2012 | 6424 | 0.020 |
Why?
|
| Animals | 3 | 2023 | 168764 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2010 | 525 | 0.020 |
Why?
|
| Lipids | 2 | 2012 | 3315 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8733 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 65188 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2009 | 394 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2010 | 704 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 10850 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 6309 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2006 | 4015 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2023 | 6273 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 1641 | 0.020 |
Why?
|
| Sleep | 1 | 2023 | 4813 | 0.020 |
Why?
|
| Blood Volume | 1 | 2008 | 542 | 0.020 |
Why?
|
| Logistic Models | 2 | 2012 | 13266 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 10729 | 0.020 |
Why?
|
| Anthropometry | 1 | 2010 | 1338 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2009 | 1589 | 0.020 |
Why?
|
| Tilt-Table Test | 1 | 2006 | 79 | 0.020 |
Why?
|
| Nifedipine | 1 | 2006 | 220 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 15880 | 0.010 |
Why?
|
| Prostaglandins | 1 | 2006 | 396 | 0.010 |
Why?
|
| Age Distribution | 1 | 2010 | 2858 | 0.010 |
Why?
|
| Rheology | 1 | 2006 | 348 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2015 | 3561 | 0.010 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2015 | 2410 | 0.010 |
Why?
|
| Fatty Liver | 1 | 2010 | 807 | 0.010 |
Why?
|
| Radiography | 1 | 2015 | 6919 | 0.010 |
Why?
|
| Renin | 1 | 2006 | 647 | 0.010 |
Why?
|
| Energy Intake | 1 | 2011 | 2141 | 0.010 |
Why?
|
| Reference Values | 1 | 2010 | 4908 | 0.010 |
Why?
|
| Urban Population | 1 | 2011 | 2040 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2006 | 844 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 686 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 3356 | 0.010 |
Why?
|
| Rural Population | 1 | 2011 | 2317 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2844 | 0.010 |
Why?
|
| Hospitals | 1 | 2013 | 3888 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2006 | 1789 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7838 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 2975 | 0.010 |
Why?
|
| Adiposity | 1 | 2008 | 1890 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 8923 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2006 | 6322 | 0.010 |
Why?
|
| Hospitalization | 1 | 2015 | 10808 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29922 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2007 | 9649 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2005 | 2966 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 15842 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20124 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 24282 | 0.000 |
Why?
|
| Incidence | 1 | 2006 | 21480 | 0.000 |
Why?
|
| Child | 1 | 2008 | 80564 | 0.000 |
Why?
|